96 related articles for article (PubMed ID: 22211851)
1. Apparent homozygosity for p.E1841K mutation in a patient with MYH9-related disorder: a misdiagnosis for an autosomal dominant disorder?
Schlegel N; Binard S; Saposnik B
Eur J Haematol; 2012 Apr; 88(4):365-6. PubMed ID: 22211851
[No Abstract] [Full Text] [Related]
2. Nonmuscle Myosin Heavy Chain IIA Mutation Predicts Severity and Progression of Sensorineural Hearing Loss in Patients With MYH9-Related Disease.
Verver EJ; Topsakal V; Kunst HP; Huygen PL; Heller PG; Pujol-Moix N; Savoia A; Benazzo M; Fierro T; Grolman W; Gresele P; Pecci A
Ear Hear; 2016; 37(1):112-20. PubMed ID: 26226608
[TBL] [Abstract][Full Text] [Related]
3. A large family with MYH9 disorder caused by E1841K mutation suffering from serious kidney and hearing impairment and cataracts.
Hao J; Kunishima S; Guo X; Hu R; Gao W
Ann Hematol; 2012 Jul; 91(7):1147-8. PubMed ID: 22080149
[No Abstract] [Full Text] [Related]
4. Advances in the understanding of MYH9 disorders.
Kunishima S; Saito H
Curr Opin Hematol; 2010 Sep; 17(5):405-10. PubMed ID: 20601875
[TBL] [Abstract][Full Text] [Related]
5. Hematologic and genetic characterization of an MYH9-related disorder in a Chinese family.
Ma ES; Wong CL; Shek TW; Hui SP
Haematologica; 2006 Jul; 91(7):1002-3. PubMed ID: 16818291
[TBL] [Abstract][Full Text] [Related]
6. Clinical, pathological, and genetic analysis of ten patients with MYH9-related disease.
Sun XH; Wang ZY; Yang HY; Cao LJ; Su J; Yu ZQ; Bai X; Ruan CG
Acta Haematol; 2013; 129(2):106-13. PubMed ID: 23207509
[TBL] [Abstract][Full Text] [Related]
7. Glomerular pathology in autosomal dominant MYH9 spectrum disorders: what are the clues telling us about disease mechanism?
Kopp JB
Kidney Int; 2010 Jul; 78(2):130-3. PubMed ID: 20588287
[TBL] [Abstract][Full Text] [Related]
8. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
Kunishima S
Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
[TBL] [Abstract][Full Text] [Related]
9. Apparent genotype-phenotype mismatch in a patient with MYH9-related disease: when the exception proves the rule.
Gresele P; De Rocco D; Bury L; Fierro T; Mezzasoma AM; Pecci A; Savoia A
Thromb Haemost; 2013 Sep; 110(3):618-20. PubMed ID: 23925420
[No Abstract] [Full Text] [Related]
10. Analysis of clinical manifestations, mutant gene and encoded protein in two Chinese MYH9-related disease families.
Yi Y; Sen Zhang G; Xu M; San Ling Z; Ru Shao X; Zeng Li J; Ma J
Clin Chim Acta; 2006 Nov; 373(1-2):49-54. PubMed ID: 16806139
[TBL] [Abstract][Full Text] [Related]
11. Mutations in MYH9 exons 1, 16, 26, and 30 are infrequently found in Japanese patients with nonsyndromic deafness.
Kunishima S; Matsunaga T; Ito Y; Saito H
Genet Test Mol Biomarkers; 2009 Oct; 13(5):705-7. PubMed ID: 19645626
[TBL] [Abstract][Full Text] [Related]
12. [MYH9-related macrothrombocytopenia].
Nivet T; Gobert D; Mekinian A; Bibi-Triki T; Fain O
Rev Prat; 2014 Jun; 64(6):758. PubMed ID: 25090750
[No Abstract] [Full Text] [Related]
13. Early diagnosis improves the quality of life in MYH9 disorder.
Shiota M; Kunishima S; Hamabata T; Nakata M; Hata D
Pediatr Blood Cancer; 2012 Feb; 58(2):314-5. PubMed ID: 21796764
[No Abstract] [Full Text] [Related]
14. Expression of non-muscle type myosin heavy polypeptide 9 (MYH9) in mammalian cells.
Takubo T; Wakui S; Daigo K; Kurokata K; Ohashi T; Katayama K; Hino M
Eur J Histochem; 2003; 47(4):345-52. PubMed ID: 14706930
[TBL] [Abstract][Full Text] [Related]
15. [Identification of MYH9 gene mutation in a May-Hegglin anomaly family].
Gao F; Hao JH; Wang ZL
Zhonghua Xue Ye Xue Za Zhi; 2012 Aug; 33(8):660-2. PubMed ID: 23134864
[No Abstract] [Full Text] [Related]
16. [A non-familial May-Hegglin anomaly accompanying with MYH9 gene R1933X mutation and I1626V polymorphism].
Li Y; Wang YW; Zhang GS; Fang MY
Zhonghua Xue Ye Xue Za Zhi; 2009 Sep; 30(9):577-81. PubMed ID: 19954613
[TBL] [Abstract][Full Text] [Related]
17. Report of a young girl with MYH9 mutation and review of the literature.
Landi D; Lockhart E; Miller SE; Datto M; Rehder C; Kanaly A; Thornburg CD
J Pediatr Hematol Oncol; 2012 Oct; 34(7):538-40. PubMed ID: 23007341
[TBL] [Abstract][Full Text] [Related]
18. Description of a novel mutation leading to MYH9-related disease.
Burt RA; Joseph JE; Milliken S; Collinge JE; Kile BT
Thromb Res; 2008; 122(6):861-3. PubMed ID: 18676005
[No Abstract] [Full Text] [Related]
19. Identification of a novel MYH9 mutation in a patient with May-Hegglin anomaly.
Otsubo K; Kanegane H; Nomura K; Ogawa J; Miyawaki T; Kunishima S
Pediatr Blood Cancer; 2006 Dec; 47(7):968-9. PubMed ID: 16642488
[No Abstract] [Full Text] [Related]
20. A novel MYH9 mutation in a patient with MYH9 disorders and platelet size-specific effect of romiplostim on macrothrombocytopenia.
Yamanouchi J; Hato T; Kunishima S; Niiya T; Nakamura H; Yasukawa M
Ann Hematol; 2015 Sep; 94(9):1599-600. PubMed ID: 26051904
[No Abstract] [Full Text] [Related]
[Next] [New Search]
